Trial intelligence / Profile preview

COLT: Colchicine in Acute Proximal Deep Vein Thrombosis

NCT07432529Phase 3Not yet recruiting

Sponsor
Azienda Sanitaria Locale 6 Livorno
Start
Jun 2026
Primary completion
Jun 2027
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01

Overview

A Phase 3 trial of colchicine in deep vein thrombosis (DVT), sponsored by Azienda Sanitaria Locale 6 Livorno. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

colchicine
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT07432529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07432529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call